当前位置: 首页 > 期刊 > 《中国医学创新》 > 2019年第31期
编号:13441243
C11orf65、SLC47A1基因多态性与二甲双胍临床疗效的相关性分析(5)
http://www.100md.com 2019年11月5日 《中国医学创新》 2019年第31期
     [12] Zhou K,Bellenguez C,SPencer C C,et al.Common variants near ATM are associated with glycemic resPonse to metformin in TyPe 2 diabetes[J].Nat Genet,2011,43(2):117-120.

    [13] van Leeuwen N,Nijpels G,Becker M L,et al.A Gene Variant near ATM is Significantly Associated with Metformin Treatment Response in Type 2 Diabetes: a Replication and meta-Analysis of Five Cohorts[J].Diabetologia,2012,55(7):1971-1977.

    [14] Florez J C,Jablonski K,Taylor A,et al.The C allele of ATM rs11212617 Does not Associate with Metformin response in the Diabetes Prevention Program[J].Diabetes Care,2012,35(9):1864-1867.

    [15] Meyer zu Schwabedissen H E,Verstuyft C,Kroemer H K,et al.Human multidrug and toxin extrusion 1 (MATE/SLC47A1) transporter: functional characterization, interaction with OCT2 (SLC22A2), and single nucleotide polymorphisms[J].Am J Physiol Renal Physiol,2010,298(4):997-1005.

    [16]張思敏,唐勇,蔡德鸿,等.一个ATM基因的常见变异与二甲双胍的降糖疗效有关[A].中华医学会糖尿病学分会第十六次全国学术会议论文集,2012.

    (收稿日期:2019-09-24) (本文编辑:周亚杰), 百拇医药(闵翼 许雄伟)
上一页1 2 3 4 5